SCHEDULE: FMR LLC Updates Generation Bio Stake to 3.5%
Beneficial Ownership Update
FMR LLC and Abigail P. Johnson have updated their beneficial ownership in Generation Bio to 3.5% of the class, as disclosed in a recent Schedule 13G/A filing.
Summary
- FMR LLC and Abigail P. Johnson reported beneficial ownership of 2,345,624 shares of Generation Bio.
- This represents 3.5% of the class of securities.
- The filing is an Amendment No. 7, indicating an update to a previously reported stake.
- FMR LLC holds sole voting power over 2,332,717 shares and sole dispositive power over 2,345,624 shares.
- Abigail P. Johnson holds sole dispositive power over 2,345,624 shares.
- The filing confirms ownership is 5% or less of the class, consistent with a passive investment intent.
Sentiment
Score: 5
Explanation: Neutral. This is a routine regulatory filing disclosing a change in beneficial ownership, not an operational or financial update. The reduction in stake below 5% is a factual disclosure without inherent positive or negative sentiment from the filing itself.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a change in beneficial ownership by a large institutional investor (FMR LLC, parent of Fidelity) in a biotechnology company, Generation Bio. Such changes are common and reflect portfolio adjustments rather than specific industry trends, unless the stake change is significant or part of a broader trend across the sector. Here, it indicates a reduction in stake below the 5% threshold.
Comparison to Industry Standards
- This is a standard regulatory disclosure required when an institutional investor's beneficial ownership falls below 5% of a company's outstanding shares.
- The ownership percentage of 3.5% is below the 5% threshold that typically triggers more detailed reporting (Schedule 13D), indicating a passive investment intent.
Stakeholder Impact
- Primarily impacts investors interested in institutional ownership trends, as a reduction below 5% might signal a reduced conviction by the investor, but it does not directly impact the company's operations, employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 2023-05-23 | Effective date of Power of Attorney for Richard Bourgelas. |
| 2023-08-08 | Date of previous Schedule 13G filing by FMR LLC (accession number -23-002397) where Power of Attorney was incorporated by reference. |
| 2025-06-30 | Date of event which requires filing of this statement. |
| 2025-08-05 | Signature date of the Schedule 13G/A filing. |
Keywords
Generation Bio, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Biotechnology, SEC Filing, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.